In this study, we combined experiments in vitro with network pharmacology to explore the characteristics of Yangxinshi and revealed the potential effect of it on CF via Cbl-b/Smad signal pathway in DCM, providing ideas for the future research of traditional Chinese medicine for the treatment of CF in DCM. Here, CBLB is linked to cystic fibrosis.